Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Published in: Current Urology Reports 10/2018

01-10-2018 | New Imaging Techniques (S Rais-Bahrami and K Porter, Section Editors)

Imaging Protocols for Active Surveillance in Renal Cell Carcinoma

Authors: Christine W. Liaw, Jared S. Winoker, Reza Mehrazin

Published in: Current Urology Reports | Issue 10/2018

Login to get access

Abstract

Purpose of Review

To review the growth kinetics of small renal masses and available imaging modalities for mass characterization and surveillance, highlight current organizational recommendations for the active surveillance of small renal masses, and discuss the most recently reported oncological outcomes of patients as they relate to various surveillance imaging protocols and progression to delayed intervention.

Recent Findings

Overall, organizational guideline recommendations are broad and lack specifics regarding timing and modality for follow-up imaging of small renal masses. Additionally, despite general consensus in the literature about certain criteria to trigger delayed intervention, there exist no formal guidelines.

Summary

Active surveillance of small renal masses is an acceptable management strategy for patients with prohibitive surgical risk; however, standardized imaging protocols for surveillance are lacking, as are randomized, prospective trials to evaluate the ideal follow-up protocol.
Literature
1.
• Campbell SC, Novick AC, Belldegrun A, et al. Guideline for the management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9. This organizational guideline has one of the more comprehensive current recommendations and is the only guideline to recommend a trigger (growth rate) for delayed intervention. CrossRefPubMed
2.
•• Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31. This review provides insight into the natural history of small renal masses and helps to establish the relative safety of active surveillance. Overall, growth rate of these lesions is slow and metastatic and cancer-specific mortality is low. CrossRefPubMed
3.
Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol. 2009;181:29–33.CrossRefPubMed
4.
Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20.CrossRefPubMed
5.
Kunkle DA, Crispen PL, Li T, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol. 2007;177:1692–6.CrossRefPubMed
6.
Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181:2033–6.CrossRefPubMedPubMedCentral
7.
Mason RJ, Abdolell M, Trottier G, Pringle C, Lawen JG, Bell DG, et al. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol. 2011;59(5):863–7.CrossRefPubMed
8.
Kunkle DA, Chen DY, Greenberg RE, et al. Metastatic progression of enhancing renal masses under active surveillance is associated with rapid interval growth of the primary tumor. J Urol. 2008;179(Suppl. 4):375.CrossRef
9.
Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DYT, et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer. 2012;118:997–1006.CrossRefPubMed
10.
Li XS, Yao L, Gong K, Yu W, He Q, Zhou LQ, et al. Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol. 2012;138:269–74.CrossRefPubMed
11.
Zhang L, Yin W, Yao L, et al. Growth pattern of clear cell renal cell carcinoma in patients with delayed surgical intervention: fast growth rate correlates with high grade and may result in poor prognosis. Biomed Res Int. 2015;2015:598134.PubMedPubMedCentral
12.
Mehrazin R, Smaldone MC, Egleston B, et al. Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?, Urol Oncol. 2015;33(4):167.e7–12.
13.
Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, Chang P, et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol. 2015;68(3):408–15.CrossRefPubMed
14.
15.
Park SW, Lee SS, Lee DH, Nam JK, Chung MK. Growth kinetics of small renal mass: initial analysis of active surveillance registry. Investig Clin Urol. 2017;58(6):429–33.CrossRefPubMedPubMedCentral
16.
Beisland C, Hjelle KM, Reisaeter LAR, Bostad L. Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Eur Urol. 2009;55:1419–29.CrossRefPubMed
17.
Rosales JC, Haramis G, Moreno J, Badani K, Benson MC, McKiernan J, et al. Active surveillance for renal cortical neoplasms. J Urol. 2010;183:1698–702.CrossRefPubMed
18.
Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DYT, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051–7.CrossRefPubMed
19.
Kunkle DA, Crispen PL, Chen DY, et al. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849–53.CrossRefPubMed
20.
Uzosike AC, Patel HD, Alam R, Schwen ZR, Gupta M, Gorin MA, et al. Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM registry. J Urol. 2018;199(3):641–8.CrossRefPubMed
21.
Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009;115:2844–52.CrossRefPubMedPubMedCentral
22.
23.
Krishna S, Murray CA, McInnes MD, et al. CT imaging of solid renal masses: pitfalls and solutions. Clin Radiol. 2017;72:708–21.CrossRefPubMed
24.
Ramamurthy NK, Moosavi B, McInnes MDF, et al. Multiparametric MRI of solid renal masses: pearls and pitfalls. Clin Radiol. 2015;70:304–16.CrossRefPubMed
25.
26.
Sun MRM, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes - correlation with pathologic findings. Radiology. 2009;250:793–802.CrossRefPubMed
27.
Pedrosa I, Chou MT, Ngo L, H. Baroni R, Genega EM, Galaburda L, et al. MR classification of renal masses with pathologic correlation. Eur Radiol. 2008;18(2):365–75.CrossRefPubMed
28.
Bata P, Gyebnar J, Tarnoki DL, Tarnoki AD, Kekesi D, Szendroi A, et al. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn Interv Radiol. 2013;19(5):387–92.PubMed
29.
Millet I, Doyon FC, Hoa D, Thuret R, Merigeaud S, Serre I, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol. 2011;197:887–96.CrossRefPubMed
30.
Egbert ND, Caoili EM, Cohan RH, Davenport MS, Francis IR, Kunju LP, et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol. 2013;201:347–55.CrossRefPubMed
31.
Gorin MA, Rowe SP, Allaf ME. Nuclear imaging of renal tumours: a step towards improved risk stratification. Nat Rev Urol. 2015;12:445–50.CrossRefPubMed
32.
Farber NJ, Wu Y, Zou L, et al. Challenges in RCC imaging: renal insufficiency, post-operative surveillance, and the role of radiomics. Kidney Cancer J. 2015;13:84.PubMedPubMedCentral
33.
James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, et al. Measure response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst. 1999;91:523–8.CrossRefPubMed
34.
Punnen S, Haider MA, Lockwood G, Moulding F, O’Malley ME, Jewett MAS. Variability in size measurement of renal masses smaller than 4 cm on computerized tomography. J Urol. 2006;176:2386–90.CrossRefPubMed
35.
Dachman AH, MacEneaney PM, Adedipe A, et al. Tumor size on computed tomography scans: is one measurement enough? Cancer. 2001;91:555–60.CrossRefPubMed
36.
NCCN Clinical practice guidelines in oncology, kidney Cancer, version 2.2016. National Comprehensive Cancer Network.
37.
Mucksavage P, Kutikov A, Magerfleisch L, van Arsdalen K, Wein AJ, Ramchandani P, et al. Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? BJU Int. 2011;108(8 Pt 2):E232–6.CrossRefPubMed
38.
Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(6):668–80.CrossRefPubMed
39.
40.
41.
McIntosh AG, Ristau BT, Ruth K, et al. Active surveillance for localized renal masses: tumor growth, delayed intervention rates, and >5-yr clinical outcomes. Eur Urol 2018 3, S0302–2838(18)30187-8.
42.
Jewett MA, Mattar K, Basiuk J, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60:39–44.CrossRefPubMed
43.
Mehrazin R, Smaldone MC, Kutikov A, et al. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014;192(3):659–64.CrossRefPubMedPubMedCentral
Metadata
Title
Imaging Protocols for Active Surveillance in Renal Cell Carcinoma
Authors
Christine W. Liaw
Jared S. Winoker
Reza Mehrazin
Publication date
01-10-2018
Publisher
Springer US
Published in
Current Urology Reports / Issue 10/2018
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-018-0830-z

Other articles of this Issue 10/2018

Current Urology Reports 10/2018 Go to the issue

New Imaging Techniques (S Rais-Bahrami and K Porter, Section Editors)

Approaches to Eliminate Radiation Exposure in the Management of Pediatric Urolithiasis

Urothelial Cancer (S Daneshmand, Section Editor)

Enhanced Endoscopy in Bladder Cancer

FEMALE UROLOGY (L COX, SECTION EDITOR)

Laser Therapy for Genitourinary Syndrome of Menopause

Prostate Cancer (S Prasad, Section Editor)

Contemporary Management of the Newly Diagnosed Prostate Cancer Patient with Metastatic Disease at Presentation

Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)

Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate

Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)

Troubleshooting Interstim Sacral Neuromodulation Generators to Recover Function